Virtual Biopsy Market Size, Share and Forecast 2025 to 2034

Report Id: 2933 Pages: 180 Last Updated: 02 January 2026 Format: PDF / PPT / Excel / Power BI
Share With : linkedin twitter facebook

Segmentation of Virtual Biopsy Market :

By Type of Therapeutic Area-

  • Oncological Disorders
  • Neurological Disorders
  • Cardiovascular Disorders
  • Ophthalmological Disorders
  • Endocrine Disorders
  • Gastrointestinal Disorders
  • Others

Virtual Biospy Market

By Type of Cancer-

  • Solid Malignancies
  • Breast Cancer
  • Lung Cancer
  • Prostate Cancer
  • Colorectal Cancer
  • Brain Cancer
  • Others

By Type of Imaging Technology-

  • Magnetic Resonance Imaging
  • Computed Tomography
  • X-ray
  • Ultrasound
  • Others

By End-User-

  • Hospitals and Clinics
  • Research Institutions
  • Diagnostic Centers
  • Others

By Region-

North America-

  • The US
  • Canada
  • Mexico

Europe-

  • Germany
  • The UK
  • France
  • Italy
  • Spain
  • Rest of Europe

Asia-Pacific-

  • China
  • Japan
  • India
  • South Korea
  • South East Asia
  • Rest of Asia Pacific

Latin America-

  • Brazil
  • Argentina
  • Rest of Latin America

 Middle East & Africa-

  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa

Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions

Chapter 2. Executive Summary

Chapter 3. Global Virtual Biopsy Market Snapshot

Chapter 4. Global Virtual Biopsy Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Porter's Five Forces Analysis
4.7. Incremental Opportunity Analysis (US$ MN), 2024-2034
4.8. Competitive Landscape & Market Share Analysis, By Key Player (2023)
4.9. Use/impact of AI on Virtual Biopsy Market Industry Trends
4.10. Global Virtual Biopsy Market Penetration & Growth Prospect Mapping (US$ Mn), 2021-2034

Chapter 5. Virtual Biopsy Market Segmentation 1: By Type of Target Therapeutic Area, Estimates & Trend Analysis
5.1. Market Share by Type of Target Therapeutic Area, 2024 & 2034
5.2. Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following Type of Target Therapeutic Area:
5.2.1. Oncological Disorders
5.2.2. Neurological Disorders
5.2.3. Cardiovascular Disorders
5.2.4. Ophthalmological Disorders
5.2.5. Endocrine Disorders
5.2.6. Gastrointestinal Disorders
5.2.7. Others

Chapter 6. Virtual Biopsy Market Segmentation 2: By Type of Cancer Targeted, Estimates & Trend Analysis
6.1. Market Share by Type of Cancer Targeted, 2024 & 2034
6.2. Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following Type of Cancer Targeted:
6.2.1. Solid Malignancies
6.2.2. Breast Cancer
6.2.3. Lung Cancer
6.2.4. Prostate Cancer
6.2.5. Colorectal Cancer
6.2.6. Brain Cancer
6.2.7. Others

Chapter 7. Virtual Biopsy Market Segmentation 3: By Type of Imaging Technology, Estimates & Trend Analysis
7.1. Market Share by Type of Imaging Technology, 2024 & 2034
7.2. Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following Type of Imaging Technology:
7.2.1. Magnetic Resonance Imaging
7.2.2. Computed Tomography
7.2.3. X-ray
7.2.4. Ultrasound
7.2.5. Others

Chapter 8. Virtual Biopsy Market Segmentation 4: By End Users, Estimates & Trend Analysis
8.1. Market Share by End Users, 2024 & 2034
8.2. Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following End Users:
8.2.1. Hospitals and Clinics
8.2.2. Research Institutions and Diagnostic Centers
8.2.3. Others

Chapter 9. Virtual Biopsy Market Segmentation 5: Regional Estimates & Trend Analysis
9.1. Global Virtual Biopsy Market, Regional Snapshot 2024 & 2034
9.2. North America
9.2.1. North America Virtual Biopsy Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
9.2.1.1. US
9.2.1.2. Canada
9.2.2. North America Virtual Biopsy Market Revenue (US$ Million) Estimates and Forecasts by Type of Target Therapeutic Area, 2021-2034
9.2.3. North America Virtual Biopsy Market Revenue (US$ Million) Estimates and Forecasts by Type of Cancer Targeted, 2021-2034
9.2.4. North America Virtual Biopsy Market Revenue (US$ Million) Estimates and Forecasts by Type of Imaging Technology, 2021-2034
9.2.5. North America Virtual Biopsy Market Revenue (US$ Million) Estimates and Forecasts by End Users, 2021-2034
9.3. Europe
9.3.1. Europe Virtual Biopsy Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
9.3.1.1. Germany
9.3.1.2. U.K.
9.3.1.3. France
9.3.1.4. Italy
9.3.1.5. Spain
9.3.1.6. Rest of Europe
9.3.2. Europe Virtual Biopsy Market Revenue (US$ Million) Estimates and Forecasts by Type of Target Therapeutic Area, 2021-2034
9.3.3. Europe Virtual Biopsy Market Revenue (US$ Million) Estimates and Forecasts by Type of Cancer Targeted, 2021-2034
9.3.4. Europe Virtual Biopsy Market Revenue (US$ Million) Estimates and Forecasts by Type of Imaging Technology, 2021-2034
9.3.5. Europe Virtual Biopsy Market Revenue (US$ Million) Estimates and Forecasts by End Users, 2021-2034
9.4. Asia Pacific
9.4.1. Asia Pacific Virtual Biopsy Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
9.4.1.1. India
9.4.1.2. China
9.4.1.3. Japan
9.4.1.4. Australia
9.4.1.5. South Korea
9.4.1.6. Hong Kong
9.4.1.7. Southeast Asia
9.4.1.8. Rest of Asia Pacific
9.4.2. Asia Pacific Virtual Biopsy Market Revenue (US$ Million) Estimates and Forecasts by Type of Target Therapeutic Area, 2021-2034
9.4.3. Asia Pacific Virtual Biopsy Market Revenue (US$ Million) Estimates and Forecasts by Type of Cancer Targeted, 2021-2034
9.4.4. Asia Pacific Virtual Biopsy Market Revenue (US$ Million) Estimates and Forecasts by Type of Imaging Technology, 2021-2034
9.4.5. Asia Pacific Virtual Biopsy Market Revenue (US$ Million) Estimates and Forecasts by End Users, 2021-2034
9.5. Latin America
9.5.1. Latin America Virtual Biopsy Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
9.5.1.1. Brazil
9.5.1.2. Mexico
9.5.1.3. Rest of Latin America
9.5.2. Latin America Virtual Biopsy Market Revenue (US$ Million) Estimates and Forecasts by Type of Target Therapeutic Area, 2021-2034
9.5.3. Latin America Virtual Biopsy Market Revenue (US$ Million) Estimates and Forecasts by Type of Cancer Targeted, 2021-2034
9.5.4. Latin America Virtual Biopsy Market Revenue (US$ Million) Estimates and Forecasts by Type of Imaging Technology, 2021-2034
9.5.5. Latin America Virtual Biopsy Market Revenue (US$ Million) Estimates and Forecasts by End Users, 2021-2034
9.6. Middle East & Africa
9.6.1. Middle East & Africa Wind Turbine Rotor Blade Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
9.6.1.1. GCC Countries
9.6.1.2. Israel
9.6.1.3. South Africa
9.6.1.4. Rest of Middle East and Africa
9.6.2. Middle East & Africa Virtual Biopsy Market Revenue (US$ Million) Estimates and Forecasts by Type of Target Therapeutic Area, 2021-2034
9.6.3. Middle East & Africa Virtual Biopsy Market Revenue (US$ Million) Estimates and Forecasts by Type of Cancer Targeted, 2021-2034
9.6.4. Middle East & Africa Virtual Biopsy Market Revenue (US$ Million) Estimates and Forecasts by Type of Imaging Technology, 2021-2034
9.6.5. Middle East & Africa Virtual Biopsy Market Revenue (US$ Million) Estimates and Forecasts by End Users, 2021-2034

Chapter 10. Competitive Landscape
10.1. Major Mergers and Acquisitions/Strategic Alliances

10.2. Company Profiles
10.2.1. GE Healthcare
10.2.1.1. Business Overview
10.2.1.2. Key Type of Target Therapeutic Area/Service Overview
10.2.1.3. Financial Performance
10.2.1.4. Geographical Presence
10.2.1.5. Recent Developments with Business Strategy
10.2.2. Imaging Biometrics
10.2.3. OptoVibronex
10.2.4. ImageBiopsy Lab
10.2.5. Median Technologies
10.2.6. Quibim
10.2.7. Siemens Healthineers
10.2.8. City Imaging and Clinical Labs

Research Design and Approach

This study employed a multi-step, mixed-method research approach that integrates:

  • Secondary research
  • Primary research
  • Data triangulation
  • Hybrid top-down and bottom-up modelling
  • Forecasting and scenario analysis

This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.

Secondary Research

Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.

Sources Consulted

Secondary data for the market study was gathered from multiple credible sources, including:

  • Government databases, regulatory bodies, and public institutions
  • International organizations (WHO, OECD, IMF, World Bank, etc.)
  • Commercial and paid databases
  • Industry associations, trade publications, and technical journals
  • Company annual reports, investor presentations, press releases, and SEC filings
  • Academic research papers, patents, and scientific literature
  • Previous market research publications and syndicated reports

These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.

Secondary Research

Primary Research

Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.

Stakeholders Interviewed

Primary interviews for this study involved:

  • Manufacturers and suppliers in the market value chain
  • Distributors, channel partners, and integrators
  • End-users / customers (e.g., hospitals, labs, enterprises, consumers, etc., depending on the market)
  • Industry experts, technology specialists, consultants, and regulatory professionals
  • Senior executives (CEOs, CTOs, VPs, Directors) and product managers

Interview Process

Interviews were conducted via:

  • Structured and semi-structured questionnaires
  • Telephonic and video interactions
  • Email correspondences
  • Expert consultation sessions

Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.

Data Processing, Normalization, and Validation

All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.

The data validation process included:

  • Standardization of units (currency conversions, volume units, inflation adjustments)
  • Cross-verification of data points across multiple secondary sources
  • Normalization of inconsistent datasets
  • Identification and resolution of data gaps
  • Outlier detection and removal through algorithmic and manual checks
  • Plausibility and coherence checks across segments and geographies

This ensured that the dataset used for modelling was clean, robust, and reliable.

Market Size Estimation and Data Triangulation

Bottom-Up Approach

The bottom-up approach involved aggregating segment-level data, such as:

  • Company revenues
  • Product-level sales
  • Installed base/usage volumes
  • Adoption and penetration rates
  • Pricing analysis

This method was primarily used when detailed micro-level market data were available.

Bottom Up Approach

Top-Down Approach

The top-down approach used macro-level indicators:

  • Parent market benchmarks
  • Global/regional industry trends
  • Economic indicators (GDP, demographics, spending patterns)
  • Penetration and usage ratios

This approach was used for segments where granular data were limited or inconsistent.

Hybrid Triangulation Approach

To ensure accuracy, a triangulated hybrid model was used. This included:

  • Reconciling top-down and bottom-up estimates
  • Cross-checking revenues, volumes, and pricing assumptions
  • Incorporating expert insights to validate segment splits and adoption rates

This multi-angle validation yielded the final market size.

Forecasting Framework and Scenario Modelling

Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.

Forecasting Methods

  • Time-series modelling
  • S-curve and diffusion models (for emerging technologies)
  • Driver-based forecasting (GDP, disposable income, adoption rates, regulatory changes)
  • Price elasticity models
  • Market maturity and lifecycle-based projections

Scenario Analysis

Given inherent uncertainties, three scenarios were constructed:

  • Base-Case Scenario: Expected trajectory under current conditions
  • Optimistic Scenario: High adoption, favourable regulation, strong economic tailwinds
  • Conservative Scenario: Slow adoption, regulatory delays, economic constraints

Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.

Name field cannot be blank!
Email field cannot be blank!(Use email format)
Designation field cannot be blank!
Company field cannot be blank!
Contact No field cannot be blank!
Message field cannot be blank!
6709
Security Code field cannot be blank!

Frequently Asked Questions

Virtual Biopsy Market is valued at USD 0.8 Billion in 2024 and is predicted to reach USD 2.1 Billion by the year 2034

Virtual Biopsy Market is expected to grow at a 12.3% CAGR during the forecast period for 2025-2034

GE Healthcare, Imaging Biometrics, OptoVibronex, ImageBiopsy Lab, Median Technologies, Quibim, Siemens Healthineers, City Imaging and Clinical Labs.

Therapeutic Area, Type Of Cancer, Type Of Imaging Technology, and End-user are the key segments of the Virtual Biopsy Market.

North America region is leading the Virtual Biopsy Market.

Report License Selection

Determine the Appropriate License for your Report

Get Sample Report Enquiry Before Buying